CNP-104

· COUR Pharmaceutical Development Company, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNP-104, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis [Phase 1, Phase 2]

See pricing